ATTN LogoMenu
4EWTier 6
기사 목록

Edwards Lifesciences Corp 4

0001225208-26-006777

View on SEC EDGAR

Wayne Markowitz, CVP, JAPAC of Edwards Lifesciences Corp (EW), exercised 9,628 stock options at $74.02 and sold 9,628 common shares at $85.06 on July 28, 2026, ending with 21,679.8708 shares owned directly.

On July 28, 2026, Wayne Markowitz, CVP, JAPAC of Edwards Lifesciences Corp, exercised 9,628 employee stock options at an exercise price of $74.02 per share, acquiring an equivalent number of common shares, and on the same day sold all 9,628 shares in the open market at an average price of $85.06 per share. The gross value of the shares issued upon the option exercise was approximately $712,240, and the sale proceeds totaled approximately $819,581, implying a spread of about $11.04 per share before taxes and transaction costs; this appears to be a routine option exercise-and-sell transaction rather than an open-market purchase or discretionary sale of existing holdings. Following these transactions, Markowitz reported direct ownership of 21,679.8708 shares of common stock, which, at the recent market price of roughly $83.68 per share, represent an estimated holding value of about $1.8 million, excluding any other securities or derivative interests not reflected in this Form 4.

Filing Facts

CIK
1099800
Ticker
EW
Form
4
Source Type
sec
Accession
0001225208-26-006777
Alert Tier
6
Edwards Lifesciences Corp 4 | ATTN